Charles River Announces Promotion of Dr. Christophe Berthoux as Major Step in Realignment of Its Global Sales and Marketing Orga
September 29 2008 - 5:00PM
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL)
announced today the promotion of Dr. Christophe Berthoux to the
newly-created position of Executive Vice President, Global Sales
and Marketing and Chief Commercial Officer. In this role, Dr.
Berthoux will lead the global realignment of Charles River�s Sales
and Marketing organization, the goal of which is to further enhance
the Company�s interface with its customers. �Given Dr. Berthoux�s
scientific and business training, his in-depth customer knowledge,
as well as his considerable sales and marketing experience, I am
confident that he will provide extraordinary levels of leadership
in driving this newly created global organization,� said James C.
Foster, Chairman, President and Chief Executive Officer of Charles
River. Mr. Foster continued, �Our global Sales and Marketing
organization will enhance the Company�s ability to provide
customers with a centralized, integrated approach to their drug
development programs across all business segments. As our customers
continue to transform their business models, we must evolve with
them. We view a global Sales and Marketing organization as a
milestone in the quest to truly become one with our customers.�
About Charles River Accelerating Drug Development. Exactly. Charles
River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies,
and leading academic institutions around the globe accelerate their
research and drug development efforts. Our more than 9,000
employees worldwide are focused on providing clients with exactly
what they need to improve and expedite the discovery, development
through first-in-human evaluation, and safe manufacture of new
therapies for the patients who need them. To learn more about our
unique portfolio and breadth of services, visit www.criver.com.
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Jul 2023 to Jul 2024